IL-4 Correlates With Bone Mineral Density in Men, and IL-4 Depletion May Drive Bone Loss in Men With HIV
The Journal of Infectious Diseases · 2026
DOI: 10.1093/infdis/jiaf570 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2026. Verfasst von Ighovwerha Ofotokun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, School of Medicine, Emory University. Hauptthemen laut MEDLINE: Bone Density, Interleukin-4, HIV Infections, Bone Resorption. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Abstract (Originalsprache)
Background
Fractures are common in people with HIV (PWH). Interleukin 4 (IL-4), an antiosteoclastogenic product of CD4 Th2 T cells, becomes depleted in PWH; however, its role in skeletal deterioration in PWH is unknown. We therefore examined associations between IL-4 and bone mineral density (BMD), bone resorption and formation markers (β-C-terminal telopeptide of type I collagen and osteocalcin), and the osteoclastogenic regulators receptor activator of NF-κB ligand (RANKL) and osteoprotegerin in PWH who were antiretroviral therapy (ART) naive and people without HIV (PWoH).
Methods
Commercial enzyme-linked immunosorbent assays were used to measure factors in a cohort of 37 ART-naive PWH and 28 PWoH and in an independent cohort of 29 ART-experienced PWH. BMD was quantified by bone densitometry, and IL-4 associations were analyzed by sex and HIV status via Spearman correlation and multivariable linear regression.
Results
IL-4 was significantly lower in ART-naive PWH as compared with PWoH and higher in ART-experienced PWH vs ART-naive PWH. With ART-naive PWH and PWoH combined, IL-4 correlated inversely with β-C-terminal telopeptide of type I collagen, RANKL, and RANKL/osteoprotegerin ratio in males and females, individually and when aggregated, but not in ART-naive PWH or PWoH individually. In PWoH and ART-naive PWH combined, IL-4 was significantly associated with higher lumbar spine Z score and most femoral BMD T and Z scores in males but not females.
Conclusions
IL-4 levels are reduced in treatment-naive PWH and higher in ART-experienced PWH. IL-4 positively correlates with BMD in men but not women, suggesting that IL-4 protects the male skeleton and that IL-4 decline may contribute to bone loss in men with HIV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine, School of Medicine, Emory University.
- Ponce De Leon Center, Grady Healthcare System.
- Division of Endocrinology, Metabolism, and Lipids, Department of Medicine, School of Medicine, Emory University.
- Research Department, Joseph Maxwell Cleland Atlanta VA Healthcare System.
ORCID-Profile: Sadaf Dabeer, Brahmchetna Bedi, M Neale Weitzmann
Förderung
- NIAMS NIH HHS
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
Ofotokun, I., Titanji, K., Dabeer, S., Tripathi, A. K., Bedi, B., Kirkpatrick, C. M., Nguyen, T. B., & Weitzmann, M. N. (2026). IL-4 Correlates With Bone Mineral Density in Men, and IL-4 Depletion May Drive Bone Loss in Men With HIV. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf570
Vancouver
Ofotokun I, Titanji K, Dabeer S, Tripathi AK, Bedi B, Kirkpatrick CM, et al. IL-4 Correlates With Bone Mineral Density in Men, and IL-4 Depletion May Drive Bone Loss in Men With HIV. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiaf570
BibTeX
@article{Ofotokun2026,
author = {Ofotokun, Ighovwerha and Titanji, Kehmia and Dabeer, Sadaf and Tripathi, Ashish Kumar and Bedi, Brahmchetna and Kirkpatrick, Caitlin M and Nguyen, Tran B and Weitzmann, M Neale},
title = {IL-4 Correlates With Bone Mineral Density in Men, and IL-4 Depletion May Drive Bone Loss in Men With HIV},
journal = {The Journal of Infectious Diseases},
year = {2026},
doi = {10.1093/infdis/jiaf570}
}
EUVIMED